| scholarly article | Q13442814 |
| P50 | author | Lena Claesson-Welsh | Q4942989 |
| P2093 | author name string | Sina Koch | |
| P2860 | cites work | Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation | Q22004269 |
| Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 | ||
| Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues | Q22008806 | ||
| Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 | ||
| Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
| Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema | Q22254202 | ||
| Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers | Q24291148 | ||
| A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells | Q24291278 | ||
| Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 | Q24291630 | ||
| Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling | Q24292998 | ||
| Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth | Q24293042 | ||
| Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments | Q24299236 | ||
| VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts | Q24302234 | ||
| Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF | Q24302435 | ||
| The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes | Q24303500 | ||
| VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain | Q24303927 | ||
| Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 | Q24304277 | ||
| Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF | Q24306175 | ||
| Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis | Q24309609 | ||
| Neuropilin is a receptor for the axonal chemorepellent Semaphorin III | Q24310596 | ||
| Neuropilin is a semaphorin III receptor | Q24310629 | ||
| Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases | Q24311877 | ||
| Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor | Q24311900 | ||
| Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways | Q24312658 | ||
| Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor | Q24320710 | ||
| Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor | Q24321564 | ||
| Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase | Q24336073 | ||
| Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor | Q24337514 | ||
| VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis | Q24530176 | ||
| The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells | Q24532025 | ||
| Proteolytic processing regulates receptor specificity and activity of VEGF-C. | Q24532314 | ||
| IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases | Q24533214 | ||
| Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase | Q24538742 | ||
| Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth | Q24561921 | ||
| Modes of resistance to anti-angiogenic therapy | Q24608005 | ||
| Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis | Q24608039 | ||
| Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D | Q24672582 | ||
| Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling | Q27658996 | ||
| Structural determinants of growth factor binding and specificity by VEGF receptor 2 | Q27659686 | ||
| The phosphoinositide 3-kinase pathway | Q27860738 | ||
| Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III | Q28114812 | ||
| VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin | Q28116308 | ||
| Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites | Q28119023 | ||
| Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1 | Q28140309 | ||
| VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms | Q28141270 | ||
| The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1 | Q28145820 | ||
| Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers | Q28146110 | ||
| Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins | Q28186603 | ||
| A model for gene therapy of human hereditary lymphedema | Q28191040 | ||
| Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. | Q34451462 | ||
| Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. | Q34455428 | ||
| Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability | Q34478521 | ||
| Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells | Q34496489 | ||
| Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor | Q34496547 | ||
| Notch signalling and the regulation of angiogenesis | Q34970926 | ||
| Regulation of vascular permeability by vascular endothelial growth factors. | Q35127972 | ||
| phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development | Q35965422 | ||
| How do endothelial cells orientate? | Q35992840 | ||
| Tyrosine phosphatases in vessel wall signaling | Q36017187 | ||
| Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development | Q36074211 | ||
| Neural guidance molecules regulate vascular remodeling and vessel navigation | Q36119408 | ||
| Integrin signaling is critical for pathological angiogenesis | Q36228035 | ||
| Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue | Q36433516 | ||
| The role of heparan sulphate proteoglycans in angiogenesis | Q36482141 | ||
| Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells | Q36615085 | ||
| The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. | Q36677542 | ||
| Bone marrow cells in the 'pre-metastatic niche': within bone and beyond | Q36691234 | ||
| Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. | Q36693824 | ||
| Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner | Q36760948 | ||
| NYK/FLK-1: a putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. | Q36775303 | ||
| Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization | Q36948568 | ||
| VEGF-A splicing: the key to anti-angiogenic therapeutics? | Q37035757 | ||
| Vascular and epithelial junctions: a barrier for leucocyte migration | Q37117935 | ||
| Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy | Q37135987 | ||
| Neuropilins: a versatile partner of extracellular molecules that regulate development and disease | Q37175295 | ||
| Integrin affinity modulation in angiogenesis | Q37179787 | ||
| FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? | Q37333639 | ||
| Phosphoinositide 3-kinases in cell migration | Q37340915 | ||
| Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. | Q37599022 | ||
| VEGFRs and Notch: a dynamic collaboration in vascular patterning | Q37631636 | ||
| Regulation of angiogenesis by ETS transcription factors | Q37631641 | ||
| Involvement of endothelial progenitor cells in tumor vascularization | Q37677862 | ||
| Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1). | Q37686444 | ||
| Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells | Q33689582 | ||
| Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis | Q33714947 | ||
| The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation | Q33734632 | ||
| Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. | Q33899627 | ||
| Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes | Q33940345 | ||
| Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis | Q34019593 | ||
| Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis | Q34022315 | ||
| Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins | Q34099220 | ||
| Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development | Q34162552 | ||
| Role of ETS family transcription factors in vascular development and angiogenesis | Q34246903 | ||
| Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor | Q34249827 | ||
| Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. | Q34349419 | ||
| Autocrine VEGF signaling is required for vascular homeostasis | Q34443661 | ||
| Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations | Q57137171 | ||
| Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor | Q57980717 | ||
| VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment | Q58035861 | ||
| Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation | Q58450934 | ||
| A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1 | Q61479346 | ||
| Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha | Q73150469 | ||
| Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect | Q74215451 | ||
| Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis | Q79518543 | ||
| VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells | Q82264553 | ||
| Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation | Q83177173 | ||
| Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis | Q83296438 | ||
| C-terminal heparin-binding peptide of snake venom VEGF specifically blocks VEGF-stimulated endothelial cell proliferation | Q83365023 | ||
| Signal transduction by vascular endothelial growth factor receptors | Q84461284 | ||
| The Shb adaptor protein causes Src-dependent cell spreading and activation of focal adhesion kinase in murine brain endothelial cells | Q28216634 | ||
| The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration | Q28250994 | ||
| The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells | Q28257153 | ||
| Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth | Q28278074 | ||
| Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation | Q28285842 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells | Q28363361 | ||
| Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice | Q28504776 | ||
| Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice | Q28508807 | ||
| Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium | Q28512027 | ||
| Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer | Q28574927 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 | Q28588628 | ||
| Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia | Q28589545 | ||
| Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice | Q28591776 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth | Q28594005 | ||
| High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis | Q28594191 | ||
| Focal adhesion kinase: the first ten years | Q28609173 | ||
| VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor | Q28646402 | ||
| VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding | Q28646414 | ||
| Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules | Q28646549 | ||
| Corneal avascularity is due to soluble VEGF receptor-1 | Q28755125 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis | Q29614537 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
| Dimerization of VEGF receptors and implications for signal transduction: a computational study | Q30488864 | ||
| Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis | Q30489396 | ||
| Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction | Q30496577 | ||
| Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism | Q30504482 | ||
| Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis | Q32061444 | ||
| Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns | Q33234980 | ||
| Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis | Q33553383 | ||
| Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action | Q37698859 | ||
| Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. | Q37716522 | ||
| The proliferative effect of vascular endothelial growth factor requires protein kinase C-alpha and protein kinase C-zeta | Q38329456 | ||
| Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration | Q38349883 | ||
| Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue. | Q38451455 | ||
| Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity | Q39709099 | ||
| Vascular endothelial growth factor B controls endothelial fatty acid uptake. | Q39727853 | ||
| Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib. | Q39837884 | ||
| Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma | Q39904602 | ||
| Blocking neuropilin-2 function inhibits tumor cell metastasis | Q39994431 | ||
| The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. | Q40193180 | ||
| Apoptosis of human macrophages by Flt-4 signaling: implications for atherosclerotic plaque pathology. | Q40248141 | ||
| Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer | Q40268215 | ||
| Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration | Q40290704 | ||
| Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors | Q40427768 | ||
| Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity | Q40506028 | ||
| Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction | Q40643967 | ||
| VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis | Q40713163 | ||
| Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain | Q40858040 | ||
| Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand | Q40939852 | ||
| Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant | Q41488146 | ||
| Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance | Q41606141 | ||
| Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability | Q41714210 | ||
| Structure of a VEGF-VEGF receptor complex determined by electron microscopy | Q41792412 | ||
| Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting | Q41891694 | ||
| Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium | Q42572244 | ||
| VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells | Q42815794 | ||
| Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis | Q43072819 | ||
| VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. | Q43286257 | ||
| Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output | Q43435823 | ||
| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. | Q43592482 | ||
| Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages | Q43664809 | ||
| A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain | Q43784472 | ||
| Live imaging of lymphatic development in the zebrafish | Q44238801 | ||
| Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites | Q44526093 | ||
| Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. | Q44729061 | ||
| A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia | Q45143705 | ||
| Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. | Q45934563 | ||
| Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis | Q46220745 | ||
| Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor | Q46693604 | ||
| Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver | Q46817255 | ||
| VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment | Q46823868 | ||
| Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. | Q46843965 | ||
| Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability. | Q47790199 | ||
| VEGFR-1 signaling regulates the homing of bone marrow-derived cells in a mouse stroke model | Q48340918 | ||
| Receptors for collapsin/semaphorins | Q48352679 | ||
| Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. | Q51804915 | ||
| Abnormal lymphatic vessel development in neuropilin 2 mutant mice. | Q52114149 | ||
| Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. | Q52855186 | ||
| IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. | Q53618817 | ||
| VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. | Q54529734 | ||
| Flt-1 signaling in macrophages promotes glioma growth in vivo. | Q55465812 | ||
| Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis | Q55482573 | ||
| P433 | issue | 7 | |
| P304 | page(s) | a006502 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Cold Spring Harbor Perspectives in Medicine | Q21042440 |
| P1476 | title | Signal transduction by vascular endothelial growth factor receptors | |
| P478 | volume | 2 |
| Q96680407 | 4-hydroxy-2-nonenal decreases coronary endothelial cell migration: Potentiation by aldehyde dehydrogenase 2 inhibition |
| Q90481195 | A New Era of Cardiac Cell Therapy: Opportunities and Challenges |
| Q41574359 | A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy |
| Q36314931 | A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands. |
| Q50071368 | A computational analysis of pro-angiogenic therapies for peripheral artery disease |
| Q36961818 | A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration |
| Q35572415 | A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras |
| Q60301465 | A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis |
| Q98387527 | A preliminary study of endothelial cell migration during angiogenesis using a meshless method approach |
| Q27003945 | A systems biology view of blood vessel growth and remodelling |
| Q47117976 | AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro |
| Q26748924 | Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer |
| Q57802472 | Affinity capture of polyribosomes followed by RNAseq (ACAPseq), a discovery platform for protein-protein interactions |
| Q91863172 | Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling |
| Q64965484 | Alternative Splicing in Angiogenesis. |
| Q36570882 | An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury |
| Q50631809 | An important role of endothelial hairy-related transcription factors in mouse vascular development. |
| Q64109722 | Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis |
| Q96135356 | Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment |
| Q35633420 | Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review |
| Q37645436 | Angiogenesis in the atherosclerotic plaque. |
| Q42743888 | Angiopoietin-1 facilitates recovery of hematopoiesis in radiated mice |
| Q48376921 | Annexin A8 promotes VEGF-A driven endothelial cell sprouting. |
| Q26747054 | Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents |
| Q42926957 | Anti-Angiogenic Drugs: Involvement in Cutaneous Side Effects and Wound-Healing Complication |
| Q92337853 | Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells |
| Q64958394 | Antiangiogenic Effect of Alkaloids. |
| Q36223964 | Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer |
| Q47649124 | Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway |
| Q99587938 | Apelin signaling drives vascular endothelial cells towards a pro-angiogenic state |
| Q88343738 | Arachidonic acid-evoked Ca2+ signals promote nitric oxide release and proliferation in human endothelial colony forming cells |
| Q59328955 | Are the Cognitive Alterations Present in Children Born From Preeclamptic Pregnancies the Result of Impaired Angiogenesis? Focus on the Potential Role of the VEGF Family |
| Q91138510 | Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling |
| Q39235857 | Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis |
| Q92457982 | BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway |
| Q36569445 | Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons |
| Q38917499 | Biochemical Effects of Exercise on a Fasciocutaneous Flap in a Rat Model |
| Q28071510 | Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates |
| Q36220022 | Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A. |
| Q89995945 | Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1) |
| Q38961312 | Bone Regeneration Using Gene-Activated Matrices |
| Q26826870 | Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind |
| Q89821007 | Bu Shen Zhu Yun Decoction Improves Endometrial Receptivity via VEGFR-2-Mediated Angiogenesis |
| Q35703835 | Cancer therapy and cardiovascular risk: focus on bevacizumab |
| Q36974857 | CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis. |
| Q37656119 | Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology |
| Q39187115 | Chromatin associated SETD3 negatively regulates VEGF expression |
| Q68691896 | CircAnks1a in the spinal cord regulates hypersensitivity in a rodent model of neuropathic pain |
| Q38645097 | Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review). |
| Q90035541 | Combining Ellagic Acid with Temozolomide Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Model |
| Q90699218 | Comprehensive review of targeted therapy for colorectal cancer |
| Q36273980 | Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells |
| Q34112722 | Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling |
| Q47983641 | Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis |
| Q27027713 | Control of cellular motility by neuropilin-mediated physical interactions |
| Q38090234 | Coordination of VEGF receptor trafficking and signaling by coreceptors. |
| Q64982759 | Cucurbita argyrosperma Seed Extracts Attenuate Angiogenesis in a Corneal Chemical Burn Model. |
| Q35048434 | DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis |
| Q36078454 | DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist |
| Q57125323 | Deciphering the role of hydrophobic and hydrophilic bile acids in angiogenesis using and model systems |
| Q52925752 | Deficient angiogenesis in redox-dead Cys17Ser PKARIα knock-in mice. |
| Q36053089 | Deletion of miR-150 Exacerbates Retinal Vascular Overgrowth in High-Fat-Diet Induced Diabetic Mice |
| Q42324124 | Deletion of neuropilin 2 enhances detrusor contractility following bladder outlet obstruction |
| Q49362483 | Delivery of VEGFA in bone marrow stromal cells seeded in copolymer scaffold enhances angiogenesis, but is inadequate for osteogenesis as compared with the dual delivery of VEGFA and BMP2 in a subcutaneous mouse model |
| Q88474963 | Dimerization of the voltage-sensing phosphatase controls its voltage-sensing and catalytic activity |
| Q46340126 | Dll4 and Notch signalling couples sprouting angiogenesis and artery formation |
| Q47164118 | Domain retention in transcription factor fusion genes and its biological and clinical implications: a pan-cancer study |
| Q36684301 | Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signaling |
| Q91619817 | Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A |
| Q23913301 | Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis |
| Q33786526 | Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis |
| Q35764986 | Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis |
| Q36180362 | EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models |
| Q99615416 | Effect of intersphincteric fistula tract ligation versus anal fistulectomy on pain scores and serum levels of vascular endothelial growth factor and interleukin-2 in patients with simple anal fistulas |
| Q64289797 | Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis |
| Q36578668 | Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers |
| Q36483799 | Endothelial Ca 2+ oscillations reflect VEGFR signaling-regulated angiogenic capacity in vivo. |
| Q92642755 | Endothelial Ca2+ Signaling, Angiogenesis and Vasculogenesis: just What It Takes to Make a Blood Vessel |
| Q38203875 | Endothelial heterogeneity in the umbilico-placental unit: DNA methylation as an innuendo of epigenetic diversity |
| Q38558879 | Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy. |
| Q88935614 | Enhancing the Therapeutic Potential of Olfactory Ensheathing Cells in Spinal Cord Repair Using Neurotrophins |
| Q55405963 | Epidermal-specific deletion of TC-PTP promotes UVB-induced epidermal cell survival through the regulation of Flk-1/JNK signaling. |
| Q49373130 | ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC). |
| Q37425936 | Escargot controls the sequential specification of two tracheal tip cell types by suppressing FGF signaling in Drosophila. |
| Q97093696 | Ets1 functions partially redundantly with Etv2 to promote embryonic vasculogenesis and angiogenesis in zebrafish |
| Q92642746 | Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK |
| Q52668906 | Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations. |
| Q27000351 | Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. |
| Q30276870 | Flt-1 (VEGFR-1) coordinates discrete stages of blood vessel formation |
| Q36020888 | Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling |
| Q64067696 | GIPC proteins negatively modulate Plexind1 signaling during vascular development |
| Q99560605 | Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy |
| Q92135927 | Genetic variation and function of the HIV-1 Tat protein |
| Q36031774 | Genomic analysis of Ugandan and Rwandan chicken ecotypes using a 600 k genotyping array. |
| Q38619949 | Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1. |
| Q48014497 | Glutamate Neonatal Excitotoxicity Modifies VEGF-A, VEGF-B, VEGFR-1 and VEGFR-2 Protein Expression Profiles During Postnatal Development of the Cerebral Cortex and Hippocampus of Male Rats |
| Q37653350 | Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization |
| Q33818704 | Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability |
| Q38187040 | Growth factors and early mesoderm morphogenesis: insights from the sea urchin embryo |
| Q21131825 | HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice |
| Q60920093 | Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma |
| Q60045624 | Higher plane of nutrition pre-weaning enhances Holstein calf mammary gland development through alterations in the parenchyma and fat pad transcriptome |
| Q37731561 | Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma |
| Q37501825 | Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro |
| Q64065167 | Human sFLT1 Leads to Severe Changes in Placental Differentiation and Vascularization in a Transgenic hsFLT1/rtTA FGR Mouse Model |
| Q92343419 | Hypotensive Snake Venom Components-A Mini-Review |
| Q52678835 | Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy. |
| Q33716420 | Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation |
| Q55536886 | Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms. |
| Q93015669 | Impaired Neovascularization in Aging |
| Q28544931 | In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis |
| Q100945794 | Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model |
| Q37625434 | Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation |
| Q49684144 | Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues |
| Q92999641 | Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer |
| Q38088193 | Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells |
| Q48029881 | Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion |
| Q51100722 | Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery. |
| Q35877762 | Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma |
| Q38985125 | KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer |
| Q47754576 | Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. |
| Q38894472 | Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells |
| Q38634403 | Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis |
| Q47147967 | Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis |
| Q41718028 | Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response. |
| Q92924413 | Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis |
| Q35294298 | Low glucose microenvironment of normal kidney cells stabilizes a subset of messengers involved in angiogenesis. |
| Q64276542 | Maternal protein restriction differentially alters the expression of AQP1, AQP9 and VEGFr-2 in the epididymis of rat offspring |
| Q58132098 | Mechanical Forces in Tumor Angiogenesis |
| Q38231224 | Mechanisms of endothelial cell migration |
| Q57170602 | Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review |
| Q64226777 | Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury |
| Q39020269 | Modulation of VEGF receptor 2 signaling by protein phosphatases |
| Q50423780 | Molecular Regulation of Sprouting Angiogenesis |
| Q26774636 | Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies |
| Q30841236 | Motor neurons control blood vessel patterning in the developing spinal cord |
| Q92879135 | Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression |
| Q92924530 | Multiple Targets Directed Multiple Ligands: An In Silico and In Vitro Approach to Evaluating the Effect of Triphala on Angiogenesis |
| Q93064139 | Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma |
| Q60920540 | N-acetylcysteine protects hepatocytes from hypoxia-related cell injury |
| Q90119226 | NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells |
| Q38087875 | Navigation rules for vessels and neurons: cooperative signaling between VEGF and neural guidance cues |
| Q41762927 | Need glucose to sprout: local metabolic control of angiogenesis |
| Q64891197 | Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. |
| Q89587291 | Neuropilin: Handyman and Power Broker in the Tumor Microenvironment |
| Q64275592 | Neuropilins in the Context of Tumor Vasculature |
| Q26746028 | New perspectives in glioblastoma antiangiogenic therapy |
| Q90246106 | Nintedanib ameliorates animal model of dermatitis |
| Q55312849 | Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy. |
| Q57034613 | Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells |
| Q38937915 | Notch: A multi-functional integrating system of microenvironmental signals |
| Q33842838 | Novel small peptides derived from VEGF125-136: potential drugs for radioactive diagnosis and therapy in A549 tumor-bearing nude mice |
| Q33881566 | Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc-dependent transcripts in human lung fibroblasts |
| Q46130631 | Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells |
| Q92634861 | Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization |
| Q36327911 | Ordinary and Activated Bone Grafts: Applied Classification and the Main Features. |
| Q55470224 | Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab. |
| Q41407607 | Oxidized low-density lipoprotein decreases VEGFR2 expression in HUVECs and impairs angiogenesis |
| Q47157518 | P311 Deficiency Leads to Attenuated Angiogenesis in Cutaneous Wound Healing |
| Q37461467 | PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα |
| Q42357211 | PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia |
| Q58591190 | Pathophysiology of Diabetic Retinopathy: The Old and the New |
| Q92151830 | Pericytes in Microvessels: From "Mural" Function to Brain and Retina Regeneration |
| Q44205350 | Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. |
| Q42546627 | Peroxisome proliferator‑activated receptor γ mediates porcine placental angiogenesis through hypoxia inducible factor‑, vascular endothelial growth factor‑ and angiopoietin‑mediated signaling |
| Q45071708 | Placental Growth Factor is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles |
| Q58778121 | Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes |
| Q46037889 | Podosome rosettes precede vascular sprouts in tumour angiogenesis. |
| Q38913862 | Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor |
| Q28083779 | Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time |
| Q37015817 | Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides |
| Q50086029 | Reduction of the relative centrifugal force influences cell number and growth factor release within injectable PRF-based matrices |
| Q38284407 | Regulation of signaling interactions and receptor endocytosis in growing blood vessels |
| Q37094060 | Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? |
| Q35829579 | Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. |
| Q39221209 | Response of the cerebral vasculature following traumatic brain injury |
| Q89622533 | Reverting Immune Suppression to Enhance Cancer Immunotherapy |
| Q33616384 | Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis |
| Q58697249 | Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway |
| Q64977643 | SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model. |
| Q38804261 | Semaphorins and their Signaling Mechanisms |
| Q89762331 | Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells |
| Q33620110 | Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization. |
| Q47290719 | Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules. |
| Q91871600 | Sustain, Adapt, and Overcome-Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia |
| Q28817495 | Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown |
| Q98224544 | Systems Biology Will Direct Vascular-Targeted Therapy for Obesity |
| Q45074473 | Systems Pharmacology of VEGF165b in Peripheral Artery Disease |
| Q92591242 | TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer |
| Q40219062 | Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization |
| Q26781278 | Targeting RTK Signaling Pathways in Cancer |
| Q28546317 | Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro |
| Q35959083 | The Association between VEGFR Gene Polymorphisms and Stroke: A Meta-Analysis |
| Q47136171 | The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats. |
| Q91816174 | The Extraordinary Role of Extracellular RNA in Arteriogenesis, the Growth of Collateral Arteries |
| Q64978168 | The Intestinal Lymphatic System: Functions and Metabolic Implications. |
| Q55078229 | The Janus Face of VEGF in Stroke. |
| Q37099065 | The Lymphatic System in Disease Processes and Cancer Progression |
| Q50099967 | The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling |
| Q37439707 | The Robo4 cytoplasmic domain is dispensable for vascular permeability and neovascularization |
| Q27030833 | The Role of Hypoxia-Inducible Factor in Wound Healing |
| Q91994816 | The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance |
| Q94596270 | The Role of Rho GTPases in VEGF Signaling in Cancer Cells |
| Q37586773 | The angiogenic activity of ascites in the course of ovarian cancer as a marker of disease progression |
| Q26796921 | The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis |
| Q37210936 | The delivery of therapeutic oligonucleotides |
| Q89624349 | The manifold roles of sialic acid for the biological functions of endothelial glycoproteins |
| Q35807878 | The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease |
| Q60308057 | The precise molecular signals that control endothelial cell-cell adhesion within the vessel wall |
| Q54999086 | The progress of prophylactic treatment in retinopathy of prematurity. |
| Q42366665 | The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. |
| Q38880066 | The roles of vascular endothelial growth factor in bone repair and regeneration |
| Q36192998 | Time to Decide? Dynamical Analysis Predicts Partial Tip/Stalk Patterning States Arise during Angiogenesis. |
| Q64948295 | Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function. |
| Q90194802 | Trends and Challenges in Tumor Anti-Angiogenic Therapies |
| Q26830901 | Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms |
| Q64064605 | Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3 |
| Q37565593 | Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells |
| Q42513534 | Ubiquitination of basal VEGFR2 regulates signal transduction and endothelial function |
| Q38219834 | Understanding the role of Notch in osteosarcoma |
| Q64104795 | Up-regulation of Grb2-associated binder 1 promotes hepatocyte growth factor-induced endothelial progenitor cell proliferation and migration |
| Q33573324 | VEGF targets the tumour cell |
| Q41961850 | VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration |
| Q34081464 | VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions |
| Q41810895 | VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis |
| Q42271421 | VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis |
| Q47137711 | VEGF-induced intracellular Ca2+ oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells |
| Q34480730 | VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling |
| Q64277092 | VEGF/Neuropilin Signaling in Cancer Stem Cells |
| Q42491822 | VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications |
| Q47370649 | VEGFC/VEGFR3 Signaling Regulates Mouse Spermatogonial Cell Proliferation via the Activation of AKT/MAPK and Cyclin D1 Pathway and Mediates the Apoptosis by affecting Caspase 3/9 and Bcl-2. |
| Q47100851 | VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways. |
| Q40198221 | VEGFR2 Trafficking, Signaling and Proteolysis is Regulated by the Ubiquitin Isopeptidase USP8. |
| Q47145612 | VEGFR2 alteration in Alzheimer's disease |
| Q45318084 | VEGFR2 mediated cell proliferation |
| Q51097984 | VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling. |
| Q35031502 | VEGFR3 does not sustain retinal angiogenesis without VEGFR2 |
| Q55379904 | Vascular Endothelial Growth Factor B and Its Signaling. |
| Q36417877 | Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases |
| Q38909867 | Vascular Endothelial Growth Factor Isoform-B Stimulates Neurovascular Repair After Ischemic Stroke by Promoting the Function of Pericytes via Vascular Endothelial Growth Factor Receptor-1. |
| Q27023354 | Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair |
| Q55425447 | Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. |
| Q60939630 | Vascular Endothelial Growth Factor, from Basic Research to Clinical Applications |
| Q38790301 | Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner. |
| Q38983079 | Vascular endothelial growth factor control mechanisms in skeletal growth and repair |
| Q92671018 | Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm? |
| Q36387982 | Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans |
| Q35517559 | Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension |
| Q89182402 | Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning |
| Q37345998 | Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress |
| Q33684215 | Vascular endothelial growth factor-D modulates oxidant-antioxidant balance of human vascular endothelial cells |
| Q38882640 | Vascular endothelial growth factor: a neurovascular target in neurological diseases |
| Q38418718 | Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease |
| Q42377393 | Vegfa signals through ERK to promote angiogenesis, but not artery differentiation. |
| Q90047090 | WNK1 Kinase Stimulates Angiogenesis to Promote Tumor Growth and Metastasis |
| Q91675426 | YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA |
| Q89929943 | c-Src controls stability of sprouting blood vessels in the developing retina independently of cell-cell adhesion through focal adhesion assembly |
| Q64051780 | iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications |
Search more.